News Chart Biomind Labs Inc. OTC Markets

Equities

CRSWF

CA0907021012

Delayed OTC Markets Other stock markets 03:14:29 2024-04-04 pm EDT			5-day change	1st Jan Change
0.11 ^USD	-.--%		-.--%	-89.00%

2023	Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications	CI
2023	Biomind Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

463ac74f68c2c78184993e54e31.2i0bKsGXKC7MpWRdGvQ1md7Ve659WI44NPbLQq3fWxE.nkhhbbTZYAO26UkwKrNN0O26GMUbNcptY8-EC-6MLniQcnMHsa9fRaH3UA~078a5422170ac460a1b22f4fa06dbe35